255 related articles for article (PubMed ID: 30316082)
1. Molecular imprinted S-nitrosothiols nanoparticles for nitric oxide control release as cancer target chemotherapy.
Liu T; Qiao Z; Wang J; Zhang P; Zhang Z; Guo DS; Yang X
Colloids Surf B Biointerfaces; 2019 Jan; 173():356-365. PubMed ID: 30316082
[TBL] [Abstract][Full Text] [Related]
2. Hollow S-nitrosothiols nanoparticle with polymeric brushes for nitric oxide (NO)-releasing as tumor targeted chemotherapy.
Wang J; Bi Y; Ruan H; Sun G; Cui X; Yang X; Qin C
J Biomater Sci Polym Ed; 2019 Feb; 30(2):122-136. PubMed ID: 30522414
[TBL] [Abstract][Full Text] [Related]
3. Hollow double-layered polymer nanoparticles with S-nitrosothiols for tumor targeted therapy.
Liu T; Hu J; Ma X; Kong B; Wang J; Zhang Z; Guo DS; Yang X
J Mater Chem B; 2017 Sep; 5(36):7519-7528. PubMed ID: 32264227
[TBL] [Abstract][Full Text] [Related]
4. Magnetic core-shell S-nitrosothiols nanoparticles as tumor dual-targeting theranostic platform.
Liu T; Zhang P; Huang X; Chi X; Li Z; Zhang Z; Guo DS; Yang X
Colloids Surf B Biointerfaces; 2019 Sep; 181():400-407. PubMed ID: 31174075
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Sensitive Biodegradable Nanoparticles of Molecularly Imprinted Polymer-Stabilized Fluorescent Zeolitic Imidazolate Framework-8 for Targeted Imaging and Drug Delivery.
Qin YT; Feng YS; Ma YJ; He XW; Li WY; Zhang YK
ACS Appl Mater Interfaces; 2020 Jun; 12(22):24585-24598. PubMed ID: 32390415
[TBL] [Abstract][Full Text] [Related]
6. The molecular design of S-nitrosothiols as photodynamic agents for controlled nitric oxide release.
Giles NM; Kumari S; Gang BP; Yuen CW; Billaud EM; Giles GI
Chem Biol Drug Des; 2012 Sep; 80(3):471-8. PubMed ID: 22642531
[TBL] [Abstract][Full Text] [Related]
7. Epitope Molecularly Imprinted Polymer Nanoparticles for Chemo-/Photodynamic Synergistic Cancer Therapy Guided by Targeted Fluorescence Imaging.
Peng H; Qin YT; He XW; Li WY; Zhang YK
ACS Appl Mater Interfaces; 2020 Mar; 12(11):13360-13370. PubMed ID: 32101405
[TBL] [Abstract][Full Text] [Related]
8. Hollow polymer nanoparticles with S-nitrosothiols as scaffolds for nitric oxide release.
Liu T; Zhang W; Yang X; Li C
J Colloid Interface Sci; 2015 Dec; 459():115-122. PubMed ID: 26275504
[TBL] [Abstract][Full Text] [Related]
9. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
[TBL] [Abstract][Full Text] [Related]
11. Ag@S-nitrosothiol core-shell nanoparticles for chemo and photothermal synergistic tumor targeted therapy.
Liu T; Li X; Wang J; Zhang P; Huang X; Zhang Z; Guo DS; Yang X
J Mater Chem B; 2020 Jul; 8(25):5483-5490. PubMed ID: 32475994
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
13. Self-Assembly Dual-Responsive NO Donor Nanoparticles for Effective Cancer Therapy.
Gu G; Chen C; Zhang S; Yin B; Wang J
ACS Appl Mater Interfaces; 2021 Nov; 13(43):50682-50694. PubMed ID: 34668695
[TBL] [Abstract][Full Text] [Related]
14. Light-activatable dual prodrug polymer nanoparticle for precise synergistic chemotherapy guided by drug-mediated computed tomography imaging.
Wang Z; Kuang G; Yu Z; Li A; Zhou D; Huang Y
Acta Biomater; 2019 Aug; 94():459-468. PubMed ID: 31128323
[TBL] [Abstract][Full Text] [Related]
15. Pro-Nifuroxazide Self-Assembly Leads to Triggerable Nanomedicine for Anti-cancer Therapy.
Misra SK; Wu Z; Ostadhossein F; Ye M; Boateng K; Schulten K; Tajkhorshid E; Pan D
ACS Appl Mater Interfaces; 2019 May; 11(20):18074-18089. PubMed ID: 31013055
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Specific Multiple Stimuli-Activated Dendrimeric Nanoassemblies with Metabolic Blockade Surmount Chemotherapy Resistance.
Li Y; Xu X; Zhang X; Li Y; Zhang Z; Gu Z
ACS Nano; 2017 Jan; 11(1):416-429. PubMed ID: 28005335
[TBL] [Abstract][Full Text] [Related]
17. Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.
Lin D; Cheng Q; Jiang Q; Huang Y; Yang Z; Han S; Zhao Y; Guo S; Liang Z; Dong A
Nanoscale; 2013 May; 5(10):4291-301. PubMed ID: 23552843
[TBL] [Abstract][Full Text] [Related]
18. Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells.
Surnar B; Sharma K; Jayakannan M
Nanoscale; 2015 Nov; 7(42):17964-79. PubMed ID: 26465291
[TBL] [Abstract][Full Text] [Related]
19. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
[TBL] [Abstract][Full Text] [Related]
20. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
